| Authors: |
Valle L; Department of Radiation Oncology, University of California Los Angeles, Los Angeles, CA, USA. Electronic address: lfvalle@fulbrightmail.org., Shabsovich D; David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA., de Meerleer G; Department of Radiation Oncology, University Hospital, Leuven, Belgium., Maurer T; Department of Urology, University Hospital Hamburg-Eppendorf, Hamburg, Germany; Martini-Klinik, University Hospital Hamburg-Eppendorf, Hamburg, Germany., Murphy DG; Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Australia., Nickols NG; West Los Angeles Veteran Affairs Medical Center, Los Angeles, CA, USA., Vapiwala N; Department of Radiation Oncology, University of Pennsylvania, Philadelphia, PA, USA., Calais J; Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA; Institute of Urologic Oncology, University of California Los Angeles, Los Angeles, CA, USA; Jonsson Comprehensive Cancer Center, University of California Los Angeles, Los Angeles, CA, USA., Kishan AU; Department of Radiation Oncology, University of California Los Angeles, Los Angeles, CA, USA. Electronic address: aukishan@gmail.com. |